news aktuell GmbH

ANDREAS STIHL AG & Co. KG: STIHL publishes its first sustainability report

Del
The STIHL Group has published its first sustainability report, detailing the company’s sustainability strat-egy and activities. The title of the report, “Acting for Tomorrow,” reflects the philosophy by which the business has been guided since its founding over 95 years ago.

In 2021, STIHL developed a sustainability strategy with the goal of enhancing its previous sustainability policy, consolidating its efforts to date, and significantly stepping up its ongoing activities. The family owned business has set itself ambitious targets in three focal areas — ecosystems, circularity, and care — for the time between now and 2030. STIHL’s goal in doing so is to become climate-neutral and resource-efficient while acting fairly, as it has done in the past, to continue making it easier for people to work in and with nature. Part of the company’s aim in doing so is to make a measurable contribution to achieving the United Nations’ Sustainable Development Goals (SDGs). Dr. Nikolas Stihl, the grandson of company founder Andreas Stihl and Chairman of STIHL’s Advisory and Supervisory Boards, says: “As a business rooted in forestry, we have traditionally had a deep connection with the natural world. Since our livelihood depends on nature, everything we do has always been focused on people, nature, and their power to grow. That is what drives us — and that is what we want to keep driving.”

The STIHL Sustainability Report is available online at: https://sustainabilityreport.stihl.com/2021

The complete press release and pictures are available for downloading from the STIHL website at

https://www.stihl.com/daily-pressbusiness-press.aspx.

Your contact for daily and business press:

ANDREAS STIHL AG & Co. KG

Dr. Stefan Caspari
Head of Corporate Communications and Public Relations
Andreas-Stihl-Straße 4 / 71336 Waiblingen
Phone: +49 - (0) 7151/26-1402
Fax: +49 - (0) 7151/26-81402
E-Mail: stefan.caspari@stihl.de

Bilder

Om news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Følg pressemeldinger fra news aktuell GmbH

Registrer deg med din e-postadresse under for å få de nyeste sakene fra news aktuell GmbH på e-post fortløpende. Du kan melde deg av når som helst.

Siste pressemeldinger fra news aktuell GmbH

Acousia Announces Completion of Patient Enrollment in Phase 2 PROHEAR Study Evaluating ACOU085 (INN: Bimokalner) for the Prevention of Cisplatin-Induced Ototoxicity8.1.2026 09:00:00 CET | Press release

Tübingen, Germany, January 8, 2026 Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 PROHEAR clinical study. ACOU085 (INN: Bimokalner) is a proprietary, first-in-class small molecule that has demonstrated robust and reproducible efficacy across multiple preclinical hearing loss models, including drug-induced ototoxicity. The PROHEAR Study is a double-blind, randomized, placebo-controlled, split-body, multicenter Phase 2 trial. It enrolled young male patients with metastatic testicular cancer who are scheduled to receive cisplatin-based chemotherapy. While cisplatin is a highly effective chemotherapeutic agent, cumulative doses of ≥300 mg/m² lead to clinically meaningful, permanent hearing loss in the majority of patients. Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized

Digital Subsidiary of Austrian State Printing Company Wins Infrastructure Tender for German EU Digital Identity Wallet22.12.2025 15:12:30 CET | Press release

youniqx Identity, a digital subsidiary of the Austrian State Printing Company (OSD), has won a Europe-wide tender, together with partner companies, for the infrastructure of the German EU Digital Identity Wallet (EUDI-Wallet). EU member states are required by EU regulations to provide a national version of an EU-wide valid EUDI-Wallet by the end of 2026. Citizens will be able to use the EUDI-Wallet to prove their personal identity throughout the EU

I vårt presserom finner du alle våre siste pressemeldinger, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye